Type 1 diabetes accounts for 5–10% of diabetes cases diagnosed worldwide.1 Hypoglycaemia is common and can limit efforts to tighten glucose control, lower quality of life,2 and increase mortality.3 Insulin analogues, structured education, insulin pump therapy, and continuous glucose monitoring have helped to decrease the burden of hypoglycaemia,4, 5 but it remains considerable.